![Douglas Stockdale](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas Stockdale
Operationeel Directeur bij Hillhurst Biopharmaceuticals, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Andrew Gomperts | M | - |
Hillhurst Biopharmaceuticals, Inc.
![]() Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts. | - |
Edward Gomperts | M | - |
Hillhurst Biopharmaceuticals, Inc.
![]() Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts. | - |
Jeff Friedman | M | - |
Hillhurst Biopharmaceuticals, Inc.
![]() Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 3 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Douglas Stockdale
- Persoonlijk netwerk